Servier Laboratories André Servier, Algerian-born French historian H. Servier, French composer Serviers-et-Labaume, a commune in southern France This... 179 bytes (51 words) - 20:48, 26 July 2022 |
Jacques Servier (9 February 1922 – 16 April 2014) was a French doctor and businessman. He was the founder and president of Laboratoires Servier, a pharmaceutical... 4 KB (240 words) - 07:15, 5 May 2023 |
Élisa Servier (born 5 May 1955 in Villepinte, Seine-Saint-Denis, France) is a French actor. After a childhood spent in the countryside, near Paris, Elisa... 12 KB (1,355 words) - 13:51, 20 March 2024 |
André Servier was a historian who lived in French Algeria at the beginning of the 20th century. He was chief editor of La Dépêche de Constantine, a newspaper... 8 KB (1,032 words) - 13:13, 2 November 2023 |
containing 90% diosmin and 10% hesperidin. It is manufactured by Laboratoires Servier and often used to treat or manage disorders of the blood vessels. Flavonoids... 8 KB (828 words) - 22:39, 10 March 2024 |
Agomelatine (category Laboratoires Servier) approval were ended in 2011. It was developed by the pharmaceutical company Servier. Agomelatine is used for the treatment of major depressive episodes in... 38 KB (3,461 words) - 11:07, 27 April 2024 |
Jeanne Louise Hillemacher Servier (1807-1858) was a French composer who published most of her work under the name Mme. H. Servier. Her best known work was... 6 KB (552 words) - 13:11, 26 February 2024 |
Serviers-et-Labaume (French pronunciation: [sɛʁvje e labom]; Occitan: Cervier e la Bauma) is a commune in the Gard department in southern France. Communes... 2 KB (74 words) - 13:04, 25 August 2023 |
Trimetazidine (category Laboratoires Servier) cytoprotective anti-ischemic agent developed and marketed by Laboratoires Servier (France). It is an anti-ischemic (antianginal) metabolic agent of the fatty... 26 KB (2,701 words) - 20:46, 24 April 2024 |
Perindopril (category Laboratoires Servier) imposed fines of €427,700,000 on Laboratoires Servier and 5 companies which produce generics due to Servier's abuse of their dominant market position, in... 19 KB (1,888 words) - 23:16, 25 April 2024 |
Indapamide (category Laboratoires Servier) Indapamide is a thiazide-like diuretic drug used in the treatment of hypertension, as well as decompensated heart failure. Combination preparations with... 11 KB (990 words) - 19:54, 10 March 2024 |
acid, is a medication for osteoporosis marketed as Protelos or Protos by Servier. Studies indicate it can also slow the course of osteoarthritis of the... 16 KB (1,511 words) - 05:13, 4 January 2024 |
S2CID 30220296. Perrin, Michel (17 February 2010). "Venous aneurysms". Servier – Phlebolymphology. Retrieved 14 January 2020. Azar D, Ohadi D, Rachev... 48 KB (5,367 words) - 01:58, 18 March 2024 |
account set up by one of the offshore companies. 2007 Irène Frachon Female Servier laboratories Irène Frachon is a French pulmonologist. Working at the University... 260 KB (8,331 words) - 01:01, 25 April 2024 |
Seqirus - was Novartis Vaccines Serono – Serono Pharmaceuticals Ltd Servier – Servier Laboratories Ltd Shire – Shire plc Ltd SHS – SHS International Ltd... 8 KB (815 words) - 09:15, 2 April 2024 |
image and quality of life in secondary lymphedema of the upper limb". Servier – Phlebolymphology. Archived from the original on 2019-09-03. Retrieved... 50 KB (5,432 words) - 08:21, 28 April 2024 |
Gliclazide (category Laboratoires Servier) Gliclazide, sold under the brand name Diamicron among others, is a sulfonylurea type of anti-diabetic medication, used to treat type 2 diabetes. It is... 17 KB (1,454 words) - 04:44, 3 April 2024 |
market in 2009, and in Australia in 2010. It was developed by Laboratoires Servier in the early 1990s. It is considered primarily a melatonin receptor agonist... 161 KB (18,327 words) - 22:40, 28 April 2024 |
of the figure were drawn by using pictures from Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons Attribution... 19 KB (2,174 words) - 20:59, 8 November 2023 |
identify patients suitable for immunotherapies. In October 2023, Owkin and Servier started a multi-year partnership focused on developing “better-targeted... 21 KB (1,802 words) - 00:07, 22 March 2024 |